Research and development at Genomic Vision

The Genomic Morse Code (GMC) strategy designed by Genomic Vision allows the development of highly efficient diagnostic tests and provide an accurate complementary method in some improperly diagnosed genetic diseases. Our R&D team focuses on the study of large genomic rearrangements and their involvement in cancer and genetic disorders with the aim of developing new assays for biomarker discovery and in vitro diagnostics.


Genomic Vision’s product development pipeline